fenofibrate has been researched along with Vascular Diseases in 3 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
Excerpt | Relevance | Reference |
---|---|---|
"Diabetic retinopathy was associated with ∼ 1." | 2.47 | Does microvascular disease predict macrovascular events in type 2 diabetes? ( Dodson, PM; Fioretto, P; Rosenson, RS, 2011) |
"Treatment with fenofibrate normalizes the altered lipid profile in diabetic rats, whereas benfotiamine treatment has no effect on lipid alteration in diabetic rats." | 1.35 | Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat. ( Balakumar, P; Chakkarwar, VA; Singh, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balakumar, P | 2 |
Chakkarwar, VA | 1 |
Singh, M | 1 |
Kaur, J | 1 |
Reddy, K | 1 |
Rosenson, RS | 1 |
Fioretto, P | 1 |
Dodson, PM | 1 |
1 review available for fenofibrate and Vascular Diseases
Article | Year |
---|---|
Does microvascular disease predict macrovascular events in type 2 diabetes?
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Do | 2011 |
2 other studies available for fenofibrate and Vascular Diseases
Article | Year |
---|---|
Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Chelating Agents; Diabetes Mellitu | 2009 |
The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
Topics: Animals; Arsenites; Cholesterol; Endothelium, Vascular; Fenofibrate; Hypolipidemic Agents; In Vitro | 2010 |